Af69016900076120179 RLS

PROCESSED AT :
Thyrocare
H. NO. 1-9-645,Vidyanagar,
Adikmet Road,Near SBH,
Hyderabad-500 044
NAME : LOKE RAJPAVAN(43Y/M) HOME COLLECTION :

REF. BY HOTEL HARIDWAR RESIDENCY ABIDS
: DR.
HYDERABAD 500001
TEST ASKED : AAROGYAM BASIC 1 WITH UTSH
PATIENTID : R22370709
TEST NAME TECHNOLOGY VALUE UNITS
HbA1c - (HPLC)
H.P.L.C 5.1 %
Bio. Ref. Interval. :
Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics
Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C method
AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 100 mg/dL
Bio. Ref. Interval. :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values
Please correlate with clinical conditions.
Sample Collected on (SCT) : 16 Sep 2023 06:17
Sample Received on (SRT) : 16 Sep 2023 11:03

Report Released on (RRT) : 16 Sep 2023 12:47
Sample Type : EDTA
Labcode : 1609066955/PP004 Dr Amulya MD (Path) Dr Ramya MD (Path)
Barcode : AN663774
Page : 1 of 9
PROCESSED AT :
Thyrocare
Hyderabad-500 044

REF. BY : DR. HOTEL HARIDWAR RESIDENCY ABIDS
HYDERABAD 500001
TEST NAME VALUE UNITS Bio. Ref. Interval.
TOTAL LEUCOCYTES COUNT (WBC) 8.34 X 10³ / µL 4.0 - 10.0
NEUTROPHILS 67.3 % 40-80
LYMPHOCYTE 21 % 20-40
MONOCYTES 5.6 % 2-10
EOSINOPHILS 5.2 % 1-6
BASOPHILS 0.7 % 0-2
IMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0-0.5
NEUTROPHILS - ABSOLUTE COUNT 5.61 X 10³ / µL 2.0-7.0
LYMPHOCYTES - ABSOLUTE COUNT 1.75 X 10³ / µL 1.0-3.0
MONOCYTES - ABSOLUTE COUNT 0.47 X 10³ / µL 0.2 - 1.0
BASOPHILS - ABSOLUTE COUNT 0.06 X 10³ / µL 0.02 - 0.1
EOSINOPHILS - ABSOLUTE COUNT 0.43 X 10³ / µL 0.02 - 0.5
IMMATURE GRANULOCYTES(IG) 0.02 X 10³ / µL 0-0.3
TOTAL RBC 4.69 X 10^6/µL 4.5-5.5
NUCLEATED RED BLOOD CELLS 0.01 X 10³ / µL 0.0-0.5
NUCLEATED RED BLOOD CELLS % 0.01 % 0.0-5.0
HEMOGLOBIN 14.1 g/dL 13.0-17.0
HEMATOCRIT(PCV) 44.8 % 40.0-50.0
MEAN CORPUSCULAR VOLUME(MCV) 95.5 fL 83.0-101.0
MEAN CORPUSCULAR HEMOGLOBIN(MCH) 30.1 pq 27.0-32.0
MEAN CORP.HEMO.CONC(MCHC) 31.5 g/dL 31.5-34.5
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 43.1 fL 39-46
RED CELL DISTRIBUTION WIDTH (RDW-CV) 12.4 % 11.6-14
PLATELET DISTRIBUTION WIDTH(PDW) 12.8 fL 9.6-15.2
MEAN PLATELET VOLUME(MPV) 10.6 fL 6.5-12
PLATELET COUNT 285 X 10³ / µL 150-410
PLATELET TO LARGE CELL RATIO(PLCR) 30.6 % 19.7-42.4
PLATELETCRIT(PCT) 0.3 % 0.19-0.39
Remarks : Alert!!! Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.
Please Correlate with clinical conditions.

Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow Cytometry Method
(using a semiconductor laser), and SLS- hemoglobin method)

Sample Type : EDTA
Barcode : AN663774 Page : 2 of 9
PROCESSED AT :
Thyrocare
Hyderabad-500 044

HOTEL HARIDWAR RESIDENCY ABIDS HYDERABAD
REF. BY : DR.
500001
TEST NAME OBSERVATION UNITS Bio. Ref. Interval.

Complete Urinogram
Physical Examination
VOLUME 3 mL -
COLOUR PALE YELLOW - Pale Yellow
APPEARANCE CLEAR - Clear
SPECIFIC GRAVITY < 1.003 - 1.003-1.030
PH 6.5 - 5-8
Chemical Examination
URINARY PROTEIN ABSENT mg/dL Absent
URINARY GLUCOSE ABSENT mg/dL Absent
URINE KETONE ABSENT mg/dL Absent
URINARY BILIRUBIN ABSENT mg/dL Absent
UROBILINOGEN Present 1+(2-4 mg/dl) mg/dL <=0.2
BILE SALT ABSENT - Absent
BILE PIGMENT ABSENT - Absent
URINE BLOOD ABSENT - Absent
NITRITE ABSENT - Absent
MICROALBUMIN 10 mg/L < 30
Microscopic Examination
MUCUS ABSENT - Absent
RED BLOOD CELLS ABSENT cells/HPF 0-5
URINARY LEUCOCYTES (PUS CELLS) ABSENT cells/HPF 0-5
EPITHELIAL CELLS 1 cells/HPF 0-5
CASTS ABSENT - Absent
CRYSTALS ABSENT - Absent
BACTERIA ABSENT - Absent
YEAST ABSENT - Absent
PARASITE ABSENT - Absent
Method : Manual Dipstick Method, Microscopy

Sample Type : URINE
Dr Amulya MD (Path) Dr Ramya MD (Path)
Labcode : 1609067579/PP004
Barcode : AO157880 Page : 3 of 9
PROCESSED AT :
Thyrocare
Hyderabad-500 044

REF. BY HOTEL HARIDWAR RESIDENCY ABIDS HYDERABAD
: DR.
500001
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
TOTAL CHOLESTEROL PHOTOMETRY 218 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 38 mg/dL 40-60
LDL CHOLESTEROL - DIRECT PHOTOMETRY 141 mg/dL < 100
TRIGLYCERIDES PHOTOMETRY 78 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 5.8 Ratio 3-5
TRIG / HDL RATIO CALCULATED 2.08 Ratio < 3.12
LDL / HDL RATIO CALCULATED 3.8 Ratio 1.5-3.5
HDL / LDL RATIO CALCULATED 0.27 Ratio > 0.40
NON-HDL CHOLESTEROL CALCULATED 180.84 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 15.58 mg/dL 5 - 40
Method :
CHOL - CHOLESTEROL OXIDASE, ESTERASE, PEROXIDASE
HCHO - DIRECT ENZYMATIC COLORIMETRIC
LDL - DIRECT MEASURE
TRIG - ENZYMATIC, END POINT
TC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
TRI/H - DERIVED FROM TRIG AND HDL VALUES
LDL/ - DERIVED FROM SERUM HDL AND LDL VALUES
HD/LD - DERIVED FROM HDL AND LDL VALUES.
NHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
VLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)
DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Type : SERUM
Barcode : AP119241 Page : 4 of 9

PROCESSED AT :
Thyrocare
Hyderabad-500 044

: DR.
500001
ALKALINE PHOSPHATASE PHOTOMETRY 110.33 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.37 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.08 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.29 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 14.38 U/L < 55
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 15.93 U/L < 35
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 11.56 U/L < 45
SGOT / SGPT RATIO CALCULATED 1.38 Ratio <2
PROTEIN - TOTAL PHOTOMETRY 7.16 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.32 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 2.84 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.52 Ratio 0.9 - 2
Method :
ALKP - MODIFIED IFCC METHOD
BILT - VANADATE OXIDATION
BILD - VANADATE OXIDATION
BILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES
GGT - MODIFIED IFCC METHOD
SGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
SGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
OT/PT - DERIVED FROM SGOT AND SGPT VALUES.
PROT - BIURET METHOD
SALB - ALBUMIN BCG¹METHOD (COLORIMETRIC ASSAY ENDPOINT)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES

Sample Type : SERUM

PROCESSED AT :
Thyrocare
Hyderabad-500 044

: DR.
500001
BLOOD UREA NITROGEN (BUN) PHOTOMETRY 19.85 mg/dL 7.94 - 20.07
CREATININE - SERUM PHOTOMETRY 1.02 mg/dL 0.72-1.18
BUN / SR.CREATININE RATIO CALCULATED 19.46 Ratio 9:1-23:1
UREA (CALCULATED) CALCULATED 42.48 mg/dL Adult : 17-43
UREA / SR.CREATININE RATIO CALCULATED 41.65 Ratio < 52
CALCIUM PHOTOMETRY 10.12 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 7.93 mg/dL 4.2 - 7.3
Method :
BUN - KINETIC UV ASSAY.
SCRE - CREATININE ENZYMATIC METHOD
B/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES
UREAC - DERIVED FROM BUN VALUE.
UR/CR - DERIVED FROM UREA AND SR.CREATININE VALUES.
CALC - ARSENAZO III METHOD, END POINT.
URIC - URICASE / PEROXIDASE METHOD

Sample Type : SERUM

PROCESSED AT :
Thyrocare
Hyderabad-500 044

HOTEL HARIDWAR RESIDENCY ABIDS HYDERABAD
REF. BY : DR.
500001
TSH - ULTRASENSITIVE E.C.L.I.A 4.61 µIU/mL 0.54-5.30
Comments :
The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :
USTSH - Fully Automated Electrochemiluminescence Sandwich Immunoassay
Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.

Sample Type : SERUM
PROCESSED AT :
Thyrocare
Hyderabad-500 044

REF. BY : DR. HOTEL HARIDWAR RESIDENCY ABIDS HYDERABAD
500001
TEST NAME TECHNOLOGY VALUE UNITS
EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 90 mL/min/1.73 m2
Bio. Ref. Interval. :-
> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease
Clinical Significance
The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.
Reference
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Method:- CKD-EPI Creatinine Equation
~~ End of report ~~

Sample Type : SERUM
Dr Amulya MD (Path) Dr Ramya MD (Path)
Labcode : 1609067434/PP004
CONDITIONS OF REPORTING
v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the
same patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage
that may be incurred by any person as a result of presuming the meaning or contents of the report.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc
v For clinical support please contact @8450950852,8450950853,8450950854 between 10:00 to 18:00
EXPLANATIONS
v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.
SUGGESTIONS
v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints or feedback, write to us at info@thyrocare.com or call us on
022-3090 0000 / 6712 3400
v SMS:<Labcode No.> to 9870666333
Page : 9 of 9

Af69016900076120179 RLS

Uploaded by

Copyright:

Available Formats

Af69016900076120179 RLS

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Af69016900076120179 RLS

Uploaded by

Copyright:

Available Formats

PROCESSED AT :

NAME : LOKE RAJPAVAN(43Y/M) HOME COLLECTION :

Below 5.7% : Normal Below 6.5% : Good Control

Sample Collected on (SCT) : 16 Sep 2023 06:17

Sample Received on (SRT) : 16 Sep 2023 11:03

NAME : LOKE RAJPAVAN(43Y/M) HOME COLLECTION :

Please Correlate with clinical conditions.

Sample Collected on (SCT) : 16 Sep 2023 06:17

NAME : LOKE RAJPAVAN(43Y/M) HOME COLLECTION :

TEST NAME OBSERVATION UNITS Bio. Ref. Interval.

Method : Manual Dipstick Method, Microscopy

Sample Collected on (SCT) : 16 Sep 2023 06:17

NAME : LOKE RAJPAVAN(43Y/M) HOME COLLECTION :

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

Sample Collected on (SCT) : 16 Sep 2023 06:17

Barcode : AP119241 Page : 4 of 9

NAME : LOKE RAJPAVAN(43Y/M) HOME COLLECTION :

Sample Collected on (SCT) : 16 Sep 2023 06:17

Barcode : AP119241 Page : 5 of 9

NAME : LOKE RAJPAVAN(43Y/M) HOME COLLECTION :

Sample Collected on (SCT) : 16 Sep 2023 06:17

Barcode : AP119241 Page : 6 of 9

NAME : LOKE RAJPAVAN(43Y/M) HOME COLLECTION :

TSH - ULTRASENSITIVE E.C.L.I.A 4.61 µIU/mL 0.54-5.30

Sample Collected on (SCT) : 16 Sep 2023 06:17

NAME : LOKE RAJPAVAN(43Y/M) HOME COLLECTION :

Please correlate with clinical conditions.

Sample Collected on (SCT) : 16 Sep 2023 06:17

You might also like